Infinity Pharmaceuticals Inc. (INFI) announced after the close Wednesday that Phase 1 clinical data for IPI-145 will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology and the 12th International Conference on Malignant Lymphoma.
Infinity Pharmaceuticals gapped open lower Thursday and has continued to decline in early trade, currently down 3.77 at $27.67. Shares have been falling for the last 2 weeks and have set a 5-month low. The stock has also dropped below its 200-day moving average.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.